Kailera Therapeutics, Inc. Common Stock (KLRA) — Financial Flexibility Index
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Financial Flexibility Index of -0.11x as of December 2025. Free cash flow of $-118.12 Million (operating CF $-120.21 Million minus capex $2.09 Million) represents 0% of total liabilities ($1.05 Billion). Also explore Kailera Therapeutics, Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kailera Therapeutics, Inc. Common Stock Financial Flexibility Index (2025–2025)
Historical Financial Flexibility Index trend for Kailera Therapeutics, Inc. Common Stock across 1 annual periods. Check Kailera Therapeutics, Inc. Common Stock (KLRA) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Kailera Therapeutics, Inc. Common Stock (2025–2025)
Year-by-year free cash flow to debt coverage for Kailera Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Kailera Therapeutics, Inc. Common Stock (KLRA) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-118.12 Million | $-120.21 Million | $1.05 Billion | — |